Science Explorer Back to mapMap
Discussion
Topic · Surgery

Intraperitoneal and Appendiceal Malignancies

Intraperitoneal and Appendiceal Malignancies is a research topic within Surgery. Science Explorer counts 20k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the management of peritoneal carcinomatosis from digestive tract cancers, particularly colorectal cancer and gastric cancer. It includes studies on cytoreductive surgery, intraperitoneal chemotherapy, hyperthermic intraperitoneal chemotherapy, and survival analysis in patients with peritoneal metastases. The cluster also covers topics such as pseudomyxoma peritonei, appendiceal neoplasms, and the treatment of peritoneal surface malignancy.

  • Cytoreductive Surgery
  • Intraperitoneal Chemotherapy
  • Colorectal Cancer
  • Peritoneal Metastases
  • Pseudomyxoma Peritonei
  • Hyperthermic Intraperitoneal Chemotherapy
  • Gastric Cancer
  • Appendiceal Neoplasms
  • Survival Analysis
  • Peritoneal Surface Malignancy
Research works
20k
fractional, since 1950
In the world top 10%
2.1k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+15%
the tick is no change
Largest producer
United States
29% of the 10 largest, 2022-now
Intraperitoneal and Appendiceal Malignancies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Intraperitoneal and Appendiceal Malignancies research?

By volume, the United States and China publish the most (912 and 690 works in 2022-now).

By volume, 2022-now

  1. 1 United States 912 works
  2. 2 China 690 works
  3. 3 India 298 works
  4. 4 Japan 280 works
  5. 5 United Kingdom 214 works
  6. 6 Italy 184 works
  7. 7 Türkiye 163 works
  8. 8 Spain 158 works
  9. 9 France 146 works
  10. 10 Germany 138 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.7%China: 21.7%India: 9.4%Japan: 8.8%6 others listed: 31.5%29%largest
United States912 · 28.7%China690 · 21.7%India298 · 9.4%Japan280 · 8.8%6 others listed1,003 · 31.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Intraperitoneal and Appendiceal Malignancies research?

By volume in 2022-now, Sun Yat-sen University publishes the most Intraperitoneal and Appendiceal Malignancies research, followed by The University of Texas MD Anderson Cancer Center and All India Institute of Medical Sciences.

By volume, 2022-now

  1. 1 Sun Yat-sen UniversityChina 41 works
  2. 2 The University of Texas MD Anderson Cancer CenterUnited States 39 works
  3. 3 All India Institute of Medical SciencesIndia 34 works
  4. 4 Università Cattolica del Sacro CuoreItaly 31 works
  5. 5 Harvard UniversityUnited States 28 works
  6. 6 Mayo ClinicUnited States 27 works
  7. 7 Peking UniversityChina 22 works
  8. 8 Capital Medical UniversityChina 21 works
  9. 9 Memorial Sloan Kettering Cancer CenterUnited States 20 works
  10. 10 UNSW SydneyAustralia 19 works

Who are the leading researchers in Intraperitoneal and Appendiceal Malignancies?

The most-cited researchers publishing on Intraperitoneal and Appendiceal Malignancies include Hermann Brenner, Lesley A. Stewart and Patrick M. Bossuyt.

  1. 1 Hermann Brenner Germany 343k citations
  2. 2 Lesley A. Stewart United Kingdom 308k citations
  3. 3 Patrick M. Bossuyt Netherlands 270k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Intraperitoneal and Appendiceal Malignancies?

The most cited paper in Intraperitoneal and Appendiceal Malignancies is "Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature" (Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al., 2015), with 5,277 citations. Next come "Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer" (3,738) and "Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer" (2,878).

Most cited papers
#PaperReleasedCitations
1 Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al. · Case Reports in Oncology Open access 3 Nov 2015 5,277
2 Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer Yuman Fong, Joseph G. Fortner, Ruth L. Sun et al. · Annals of Surgery Open access Sep 1999 3,738
3 Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer William Patrick McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine Open access 4 Jan 1996 2,878
4 A 5‐decade analysis of 13,715 carcinoid tumors Irvin Mark Modlin, Kevin D. Lye, Mark S. Kidd · Cancer 3 Feb 2003 2,758
5 Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer Herbert Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al. · New England Journal of Medicine Open access 27 Aug 2003 2,691
All 100 most cited papers, with filters and sorting

Where is Intraperitoneal and Appendiceal Malignancies research done?

The largest centres of Intraperitoneal and Appendiceal Malignancies research in 2022-now are Beijing (China), Tokyo (Japan), Guangzhou (China) and Seoul (South Korea).

Largest cities, 2022-now

  1. 1 BeijingChina 99 works
  2. 2 TokyoJapan 66 works
  3. 3 GuangzhouChina 66 works
  4. 4 SeoulSouth Korea 57 works
  5. 5 HoustonUnited States 52 works
  6. 6 ShanghaiChina 52 works
  7. 7 New YorkUnited States 51 works
  8. 8 IstanbulTürkiye 51 works
  9. 9 LondonUnited Kingdom 47 works
  10. 10 RomeItaly 45 works
See Intraperitoneal and Appendiceal Malignancies on the map

Where is the best place to study Intraperitoneal and Appendiceal Malignancies?

Among universities, judged by research, Università Cattolica del Sacro Cuore, Harvard University and Sun Yat-sen University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 21.04%fractional works in this field (log) →share of work in the world top 10% →Radboud University N…Università Cattolica…Harvard UniversitySun Yat-sen University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Università Cattolica del Sacro CuoreItaly 84.023.5%17.0×31 +36.5%
2Harvard UniversityUnited States 73.417.2%2.1×28 +13.8%
3Sun Yat-sen UniversityChina 72.014.2%4.8×42 +66.8%
4Radboud University NijmegenNetherlands 69.726.5%4.9×12 +5.4%
5Sichuan UniversityChina 65.526.3%2.0×19 +57.7%
6University of Southern DenmarkDenmark 63.423.0%5.1×8 +20.5%
7University of OsloNorway 60.424.4%3.7×10 +10.5%
8UNSW SydneyAustralia 57.47.7%5.0×19 +24.0%
9Southern Medical UniversityChina 57.334.5%3.2×8 +128.3%
10Yale UniversityUnited States 54.413.1%3.4×15 +98.2%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Intraperitoneal and Appendiceal Malignancies, country by country

Is Intraperitoneal and Appendiceal Malignancies research growing?

Output in 2022-2025 was 15% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Intraperitoneal and Appendiceal Malignancies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Intraperitoneal and Appendiceal Malignancies as a percentage of every work published that year, 0.020% in 2024.

still counting0.010%0.020%0.030%Intraperitoneal and Appendiceal Malignancies0.019% in 202519801990200020102020

Fractional works of Intraperitoneal and Appendiceal Malignancies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Intraperitoneal and Appendiceal Malignancies10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Intraperitoneal and Appendiceal Malignancies. Posts are plain text and can be reported.